Phase 1b/2 Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia (CTMS# 21-0097)

ClinicalTrials.gov Identifier

ClinicalTrials.gov registration not required

Principal Investigator

Anne–Marie Langevin MD

For more information about this study

View Details